Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16 USD | -6.54% | +12.68% | +75.82% |
04-17 | North American Morning Briefing : Stock Futures -2- | DJ |
04-16 | Oppenheimer Upgrades Avalo Therapeutics to Outperform From Perform, Price Target is $35 | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- AVTX Stock
- Revisions Avalo Therapeutics, Inc.